Drug intelligence / Profile preview

water O-15

Development stage
Unknown
Lead developer
MedTrace Pharma
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intrathecal, Intravenous
01

Overview

Water O-15 (oxygen-15 water, [15O]-water) is a diagnostic radiopharmaceutical consisting of water labeled with the positron-emitting isotope oxygen-15 (O-15). It is widely considered the non-invasive gold standard for the absolute quantification of tissue perfusion and blood flow using positron emission tomography (PET). Because it is metabolically inert and freely diffusible across cell membranes, its distribution and clearance are entirely dependent on regional blood flow. It is primarily being developed and investigated for myocardial perfusion imaging to detect coronary artery disease (CAD), as well as for assessing cerebral blood flow in neurological conditions (such as hydrocephalus, Alzheimer's disease, and ischemic stroke) and tumor perfusion in oncology. Due to its extremely short half-life of approximately 2 minutes, it must be produced on-site using a cyclotron and automated point-of-care synthesis and infusion systems, such as MedTrace's P3 MT-100 system.

Other names
[15O]-H2O[15O]-water[15O]H2O[15O]waterO-15 waterO15 waterO 15 waterO15-waterO-15-waterO 15-wateroxygen 15-labeled wateroxygen15-labeled wateroxygen-15-labeled wateroxygen-15 wateroxygen15 wateroxygen 15 waterradiowaterwater O 15water, O-15

Beyond the preview

Go deeper on water O-15.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on water O-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call